Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year-old Alyssa was in remission, and she continues to do well several months later.

Gene-Editing 'Scissor' Tool May Also be a 'Dimmer Switch

Health Archives, Page 76 of 327

HOPA Bulletin

News Archives - Page 1238 of 10145 - KYMA

Vector engineering, strategies and targets in cancer gene therapy

Turbocharging CRISPR to Understand How the Immune System Fights Cancer

FDA approves the first gene-editing treatment in the US

News Archives - Page 1238 of 10145 - KYMA

News Archives - Page 1238 of 10145 - KYMA

Gene therapy for cancer: A guide for patients and caregivers

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer, Molecular Cancer

Gene editing technology for treatment-resistant cancer could be a 'scientific layup' to treat other diseases

100,000 newborn babies will have their genomes sequenced in the UK. It could have big implications for child medicine

Alexa Miller on LinkedIn: CRISPR-Cas9: From Bacterial Adaptive Immune Response To Editing and…